AbbVie, Inc. (ABBV)
204.22
+6.53
(+3.30%)
USD |
NYSE |
Apr 29, 16:00
203.14
-1.08
(-0.53%)
After-Hours: 20:00
AbbVie Market Cap : 361.10B for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 182.15B |
| Biogen, Inc. | 28.54B |
| Gilead Sciences, Inc. | 159.95B |
| Johnson & Johnson | 547.28B |
| Regeneron Pharmaceuticals, Inc. | 72.58B |
Market Cap Related Metrics
| PE Ratio | 86.48 |
| PS Ratio | 5.918 |
| Price to Free Cash Flow | 20.31 |
| Price | 204.22 |
| Earnings Yield | 1.16% |
| Operating PE Ratio | 18.04 |
| Normalized PE Ratio | 29.07 |